Technical Data
C1300-01B
Carcinoembryonic Antigen (CEA)
Description:
Carcinoembryonic Antigen (CEA) is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).

Applications:
Suitable for use in ELISA and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
ELISA: Can be used for detection in sandwich ELISA with C1300-01C (coating).
Immunohistochemistry (Paraffin): Antigen retrieval is not essential but may optimize staining.
Optimal dilutions to be determined by the researcher.

Hybridoma:
Sp2/0 myeloma cells with spleen cells from Balb/c mice.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG18J503Purified
SizeStorageShippingSourceHost
200ug-20CBlue IceHumanMouse
Concentration:
~1mg/ml
Immunogen:
Human natural tumor-derived purified carcinoembryonic antigen. Cellular Localization: Plasma membrane Epitope: Epitope Group 2.
Purity:
Purified
Form
Supplied as a liquid in 10mM Tris, 0.15M sodium chloride, 0.05% sodium azide.
Specificity:
Recognizes human Carcinoembryonic Antigen (CEA). Does not crossreact with human leukocytes.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.